Peanut ( L.), also known as groundnut, is cultivated globally and is a widely consumed oilseed crop. Its nutritional composition and abundance in lipids, proteins, vitamins, and essential mineral elements position it as a nutritious food in various forms across the globe, ranging from nuts and confections to peanut butter. Cultivating peanuts provides significant challenges due to abiotic and biotic stress factors and health concerns linked to their consumption, including aflatoxins and allergens. These factors pose risks not only to human health but also to the long-term sustainability of peanut production. Conventional methods, such as traditional and mutation breeding, are time-consuming and do not provide desired genetic variations for peanut improvement. Fortunately, recent advancements in next-generation sequencing and genome editing technologies, coupled with the availability of the complete genome sequence of peanuts, offer promising opportunities to discover novel traits and enhance peanut productivity through innovative biotechnological approaches. In addition, these advancements create opportunities for developing peanut varieties with improved traits, such as increased resistance to pests and diseases, enhanced nutritional content, reduced levels of toxins, anti-nutritional factors and allergens, and increased overall productivity. To achieve these goals, it is crucial to focus on optimizing peanut transformation techniques, genome editing methodologies, stress tolerance mechanisms, functional validation of key genes, and exploring potential applications for peanut improvement. This review aims to illuminate the progress in peanut genetic engineering and genome editing. By closely examining these advancements, we can better understand the developments achieved in these areas.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646254 | PMC |
http://dx.doi.org/10.1007/s12298-024-01534-6 | DOI Listing |
Development
January 2025
Université Côte d'Azur, CNRS, INSERM, Institute for Research on Cancer and Aging, Nice (IRCAN), Nice, 06107, France.
Optimized laboratory conditions for research models are crucial for the success of scientific projects. This includes controlling the entire life cycle, having access to all developmental stages and maintaining stable physiological conditions. Reducing the life cycle of a research model can also enhance the access to biological material and speed up genetic tool development.
View Article and Find Full Text PDFDev Growth Differ
January 2025
Amphibian Research Center, Hiroshima University, Higashi-Hiroshima, Japan.
Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression, in conjunction with cyclins. The cyclin-CDK system is highly conserved among eukaryotes, and CDK1 is considered essential for progression through the M phase. However, the extent to which cell cycle progression depends on CDK1 varies between cell types.
View Article and Find Full Text PDFNew Phytol
January 2025
Department of Fruit Tree Sciences, The Volcani Center ARO, 68 HaMaccabim Road, Rishon LeZion, 7505101, Israel.
Furanocoumarins (FCs) are plant defence compounds derived from the phenylpropanoid pathway via the coumarin umbelliferone that harbour some therapeutic benefits yet are the underlying cause of 'grapefruit-drug interactions' in humans. Most of the pathway genes have not been identified in citrus. We employed a genetic/Omics approach on citrus ancestral species and F1 populations of mandarin × grapefruit and mandarin × pummelo.
View Article and Find Full Text PDFKardiol Pol
January 2025
1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.
PLoS One
December 2024
Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
The ability to determine the essentiality of a gene in the protozoan parasite Leishmania is important to identify potential targets for intervention and understanding the parasite biology. CRISPR gene editing technology has significantly improved gene targeting efficiency in Leishmania. There are two commonly used CRISPR gene targeting methods in Leishmania; the stable expression of the gRNA and Cas9 using a plasmid containing a Leishmania ribosomal RNA gene promoter (rRNA-P stable protocol) and the T7 RNA polymerase based transient gRNA expression system in promastigotes stably expressing Cas9 (T7 transient protocol).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!